The post Ethereum Foundation goes bullish on Morpho with latest 3,400 ETH DeFi stake appeared on BitcoinEthereumNews.com. The Ethereum Foundation deployed 3,400The post Ethereum Foundation goes bullish on Morpho with latest 3,400 ETH DeFi stake appeared on BitcoinEthereumNews.com. The Ethereum Foundation deployed 3,400

Ethereum Foundation goes bullish on Morpho with latest 3,400 ETH DeFi stake

For feedback or concerns regarding this content, please contact us at [email protected]

The Ethereum Foundation deployed 3,400 ETH tokens into Morpho in a move that seemed straightforward to some but left others wondering why Aave, the largest Ethereum DeFi protocol negvenever got the nod. 

In a thread posted on X today, March 18, 2025, the Ethereum Foundation announced that they transferred roughly $7.6 million worth of ETH into Morpho’s yield-bearing vaults, with 1,000 ETH specifically allocated to Morpho Vaults V2, the protocol’s latest architecture built around contracts that cannot be upgraded or interfered with by any administrator once deployed.

The move is not an isolated event either. In October 2025, the Foundation had already committed 2,400 ETH and approximately $6 million in stablecoins to Morpho, claiming it was part of a bigger strategy to move away from periodically selling ETH to fund their operations. 

The criteria for the deployment

In June 2025, the foundation, through Hsiao-Wei Wang, published a treasury policy to establish a framework it called “Defipunk,” which is a set of requirements that all future on-chain deployments must satisfy before the foundation can deploy into them. 

Some of the requirements include permissionless access, self-custody, open-source licensing, privacy, open development processes, and what the document describes as “maximally trustless core logic.”

The policy was also explicit about licensing, stating that contracts must use a free/libre open-source license (either copyleft, such as AGPL, or permissive, like MIT/Apache). However, source-available licenses like the Business Source License (or BSL) specifically do not qualify. 

Luckily, Morpho Vaults V2 and Morpho Blue V1 both operate under GPL 2.0. 

For immutability, the policy stated that the Foundation would avoid “admin keys with broad powers” and instead favor protocols where “fundamental logic of the protocol is non-upgradeable or governed by a highly-decentralized, time-locked and transparent process.” 

Morpho also clears this requirement as its V2’s core contracts are fully immutable once deployed, with no chances for administrative override of any kind.

The policy also went ahead to name specific patterns in the current DeFi space that it would not support. 

Apparently, the policy would not accept “backdoor shutdown mechanisms or funds extraction functions, excessive reliance on multisigs or MPC, pervasive use of whitelists, centralized and surveilled UIs.” 

It also stated that these patterns “leave both DeFi markets and participants exposed to systemic vulnerabilities.”

Why did the Ethereum Foundation not choose Aave?

The Ethereum Foundation did not mention Aave anywhere in its post today or in the June 2025 policy document. However, to the skeptic, it’s hard not to read terminologies about admin keys, backdoor extraction functions, and governance transparency failures without drawing parallels to the crisis that has rocked Aave publicly since December 2025.

Apparently, swap revenue from Aave’s CoW Swap integration was found in a wallet controlled by Aave Labs (instead of the DAO treasury). Marc Zeller, the founder of the Aave Chan Initiative and its most influential governance delegate, put the figure at around $51 million in unapproved fees after publishing an audit of Aave Labs’ historical funding on February 25. 

BGD Labs, the firm responsible for building and maintaining Aave V3, also announced on February 20 that it would not renew its contract after April 1 due to centralization concerns and Aave Labs’ apparent attacks on V3 to promote V4.

The governance crisis reached its climax on March 1, when the “Aave Will Win” funding proposal (requesting up to $42.5 million in stablecoins and 75,000 AAVE tokens) passed a Temp Check with a narrow 52.58% approval. 

Zeller immediately challenged the result, alleging that 233,000 votes from Aave Labs-linked clusters (including 111,000 tokens delegated by co-founder Stani Kulechov) decided the outcome, and that removing those votes would have revealed a clear rejection. 

Two days later, the Aave Chan Initiative announced it was leaving the project entirely. 

What does this mean for Morpho?

Morpho is now the only DeFi protocol that the Ethereum Foundation has invested in twice under its current treasury strategy. With a total value locked (TVL) of $5.8 billion, the endorsement comes at a period when Morpho is already starting to build institutional momentum. 

In less than eight months, Coinbase has surpassed $1 billion in Bitcoin-backed loan originations through the protocol. Additionally, Apollo Global Management also agreed to buy up to 90 million MORPHO tokens over four years through its partnership with the Morpho Association.

Nonetheless, the Ethereum Foundation’s policy simply highlights that aside from financial gain, the deployments themselves signal the kind of technical approaches and governance models that the foundation considers sustainable.

Source: https://www.cryptopolitan.com/ethereum-foundation-goes-bullish-on-morpho/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26